InvestorsHub Logo
Followers 13
Posts 1001
Boards Moderated 0
Alias Born 03/12/2009

Re: TheFinalCD post# 31775

Monday, 10/01/2018 11:40:33 AM

Monday, October 01, 2018 11:40:33 AM

Post# of 36713
HONIG and Intellect Neurosciences


SEC Orders Hearings On Registration Suspension Or Revocation Against Intellect Neurosciences, Inc. For Failure To Make Required Periodic Filings
Sep 18 18
Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of Intellect Neurosciences, Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.

https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=32390485




Dr. CHAIN took tauc3 patent after positiv results

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439699/

Funding Statement
This work was supported by a sponsored research agreement from Intellect Neurosciences INC (http://www.intellectns.com/). Intellect Neurosciences also provided the anti-TauC3 antibody. Intellect Neurosciences had no role in study design, data collection and analysis, or preparation of the manuscript. They did approve the manuscript to be published. The Massachusetts Alzheimer Disease Research Center Brain Bank provided tissue samples (P50AG005134).

No announcement from ILNS!

TAUC3 patent and Dr. CHAIN private taubiologic corp.

Inventor G Chain Daniel Current Assignee Tau Bio-Logic Corp Original Assignee Intellect Neurosciences Inc

https://patents.google.com/patent/US20160122422

https://taubiologic.com/


Jesselson invested in ILNS and Cerespir
http://google.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=11151859-2047-23224&type=sect&TabIndex=2&companyid=685048&ppu=%252fdefault.aspx%253fsym%253dILNS

https://www.sec.gov/Archives/edgar/data/1683746/000168374616000001/xslFormDX01/primary_doc.xml


Reason?

https://www.sec.gov/Archives/edgar/data/1337905/000114420413027571/v344594_ex99-1.htm


http://google.brand.edgar-online.com/?sym=ILNS

SEC INVESTIGATION

Google: foia ibl intellect neurosciences sec

Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MGTI News